No Data
No Data
Cathie Wood's Ark Invest Continues To Load Up On Tempus AI, Dumps Bitcoin-Focused Block In Tech Meltdown Aftermath
ElevateBio Taps Amazon's GenAI Tools to Design CRISPR Therapeutics
Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) Are in the Red If They Invested a Year Ago
CRISPR Therapeutics (NASDAQ:CRSP) Is In A Good Position To Deliver On Growth Plans
CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Bluebird Bio Stock Slides for Second Day on Buyout News
sooogod : nbis.
GOGOY : Tem will be the next